Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[From consensus to CBO guideline].

J J van Everdingen1

  • 1Kwaliteitsinstituut voor de Gezondheidszorg CBO, Utrecht.

Nederlands Tijdschrift Voor Geneeskunde
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Restructuring of subsidy policy: research and quality measures under pressure].

Nederlands tijdschrift voor geneeskunde·2003
Same author

[CBO guidelines 'Antiretroviral therapy in the Netherlands'].

Nederlands tijdschrift voor geneeskunde·2001
Same author

Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

[The "best" hospitals in the Netherlands; comments on results from the Elsevier survey].

Nederlands tijdschrift voor geneeskunde·2001
Same author

[CBO guidelines on diagnosis, treatment, and prevention of complication in diabetes mellitus: retinopathy, foot ulcers, nephropathy and cardiovascular diseases. Dutch Institute for Quality Assurance].

Nederlands tijdschrift voor geneeskunde·2000
Same author

['Urinary tract infections'--revised CBO guideline. Dutch Institute for Quality Assurance].

Nederlands tijdschrift voor geneeskunde·1999
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

The Dutch Institute for Health Care Improvement (CBO) develops evidence-based clinical guidelines. Their transparent approach ensures guidelines are scientifically sound and accepted by medical professionals.

Area of Science:

  • Health policy
  • Medical guideline development
  • Evidence-based practice

Context:

  • Established in 1981, the Dutch Institute for Health Care Improvement (CBO) is an independent non-profit organization.
  • The CBO's consensus development program aims to create high-quality, state-of-the-art scientific guidelines for healthcare.
  • Guidelines are developed by and for the medical profession, with recognition from government, financiers, and patient organizations.

Purpose:

  • To develop scientific healthcare guidelines that represent the current state of the art.
  • To ensure guidelines are acceptable and recognized by the medical community, government, financiers, and patients.
  • To standardize the disclosure, analysis, and weighting of scientific literature data for evidence-based medicine.

Summary:

Related Experiment Videos

  • The CBO employs a transparent methodology for guideline creation.
  • This approach addresses the need for consistent, reliable guidelines in the complex field of modern medicine.
  • The program emphasizes scientific rigor and broad acceptance within the healthcare ecosystem.

Impact:

  • Facilitates the adoption of evidence-based medicine through standardized, high-quality guidelines.
  • Enhances the credibility and utility of clinical guidelines among diverse healthcare stakeholders.
  • Contributes to improved patient care by providing reliable, scientifically validated recommendations.